Bordet Scientific Publications

Bordet Scientific Publications

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.

Blanc J, Carnot A, Barthélémy P, Casert V, Sautois B, Van den Brande J, Vanhaudenarde V, Staudacher L, Seront E, Debien V, Ameye L, Kotecki N, Rothé F, Rorive S, Fantoni JC, Tricard T, Roumeguère T, Awada A, Martinez Chanza N

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.

Blanc J, Carnot A, Barthélémy P, Casert V, Sautois B, Van den Brande J, Vanhaudenarde V, Staudacher L, Seront E, Debien V, Ameye L, Kotecki N, Rothé F, Rorive S, Fantoni JC, Tricard T, Roumeguère T, Awada A, Martinez Chanza N

Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Lobo-Martins S, Debien V, Agostinetto E, Sirico M, Carvalho GS, Jacobs F, Molinelli C, Bonadio RC, Bergmann P, Souza CP, Testa L, Nishimuni M, João Rossi A, Guimarães GK, Moreau M, De Giorgi U, Bines J, Santoro A, Taylor D, Duhoux FP, Barchiesi G, Lambertini M, Piccart M, de Azambuja E

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Lobo-Martins S, Debien V, Agostinetto E, Sirico M, Carvalho GS, Jacobs F, Molinelli C, Bonadio RC, Bergmann P, Souza CP, Testa L, Nishimuni M, João Rossi A, Guimarães GK, Moreau M, De Giorgi U, Bines J, Santoro A, Taylor D, Duhoux FP, Barchiesi G, Lambertini M, Piccart M, de Azambuja E

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Lobo-Martins S, Debien V, Agostinetto E, Sirico M, Carvalho GS, Jacobs F, Molinelli C, Bonadio RC, Bergmann P, Souza CP, Testa L, Nishimuni M, João Rossi A, Guimarães GK, Moreau M, De Giorgi U, Bines J, Santoro A, Taylor D, Duhoux FP, Barchiesi G, Lambertini M, Piccart M, de Azambuja E

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Lobo-Martins S, Debien V, Agostinetto E, Sirico M, Carvalho GS, Jacobs F, Molinelli C, Bonadio RC, Bergmann P, Souza CP, Testa L, Nishimuni M, João Rossi A, Guimarães GK, Moreau M, De Giorgi U, Bines J, Santoro A, Taylor D, Duhoux FP, Barchiesi G, Lambertini M, Piccart M, de Azambuja E

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.

Lobo-Martins S, Debien V, Agostinetto E, Sirico M, Carvalho GS, Jacobs F, Molinelli C, Bonadio RC, Bergmann P, Souza CP, Testa L, Nishimuni M, João Rossi A, Guimarães GK, Moreau M, De Giorgi U, Bines J, Santoro A, Taylor D, Duhoux FP, Barchiesi G, Lambertini M, Piccart M, de Azambuja E

Real-World 5-Year Outcomes of Patients Treated With the Adjuvant Paclitaxel Trastuzumab (APT) Regimen for Stage I HER2-Positive Early Breast Cancer: A Retrospective International Study.
Erasme hospital

Erasmus Hospital

View all of Erasmus's scientific publications

Erasmus's academic publications
Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet